Xiang Yanxiao, Zhao Hua, Wang Jiali, Zhang Luetao, Liu Anchang, Chen Yuguo
Department of Clinical Pharmacy, Qilu Hospital, Shandong University, Jinan, Shandong 250012, P.R. China; Department of Emergency, Qilu Hospital, Shandong University, Jinan, Shandong 250012, P.R. China.
Department of Orthopedics, Qilu Hospital, Shandong University, Jinan, Shandong 250012, P.R. China.
Biomed Rep. 2016 Jul;5(1):11-17. doi: 10.3892/br.2016.677. Epub 2016 May 16.
Cardiac arrest (CA) is a leading cause of fatality and long-term disability worldwide. Recent advances in cardiopulmonary resuscitation (CPR) have improved survival rates; however, the survivors are prone to severe neurological injury subsequent to successful CPR following CA. Effective therapeutic options to protect the brain from CA remain limited, due to the complexities of the injury cascades caused by global cerebral ischemia/reperfusion (I/R). Although the precise mechanisms of neurological impairment following CA-initiated I/R injury require further clarification, evidence supports that one of the key cellular pathways of cerebral injury is inflammation. The inflammatory response is orchestrated by activated glial cells in response to I/R injury. Increased release of danger-associated molecular pattern molecules and cellular dysfunction in activated microglia and astrocytes contribute to ischemia-induced cytotoxic and pro-inflammatory cytokines generation, and ultimately to delayed death of neurons. Furthermore, cytokines and adhesion molecules generated within activated microglia, as well as astrocytes, are involved in the innate immune response; modulate influx of peripheral immune and inflammatory cells into the brain, resulting in neurological injury. The present review discusses the molecular aspects of immune and inflammatory mechanisms in global cerebral I/R injury following CA and CPR, and the potential therapeutic strategies that target neuroinflammation and the innate immune system.
心脏骤停(CA)是全球范围内导致死亡和长期残疾的主要原因。心肺复苏(CPR)技术的最新进展提高了生存率;然而,心脏骤停后心肺复苏成功的幸存者容易出现严重的神经损伤。由于全脑缺血/再灌注(I/R)引起的损伤级联反应复杂,保护大脑免受心脏骤停影响的有效治疗选择仍然有限。尽管心脏骤停引发的缺血/再灌注损伤后神经功能障碍的确切机制需要进一步阐明,但有证据支持脑损伤的关键细胞途径之一是炎症。炎症反应是由活化的神经胶质细胞对缺血/再灌注损伤作出的反应所协调的。活化的小胶质细胞和星形胶质细胞中与危险相关的分子模式分子释放增加以及细胞功能障碍,导致缺血诱导的细胞毒性和促炎细胞因子生成,并最终导致神经元延迟死亡。此外,活化的小胶质细胞以及星形胶质细胞内产生的细胞因子和黏附分子参与先天免疫反应;调节外周免疫和炎症细胞流入大脑,导致神经损伤。本综述讨论了心脏骤停和心肺复苏后全脑缺血/再灌注损伤中免疫和炎症机制的分子方面,以及针对神经炎症和先天免疫系统的潜在治疗策略。